EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY-NC-ND 4.0

Evaluation of the Allplex NG & DR assay for molecular prediction of ciprofloxacin and azithromycin resistance in Neisseria gonorrhoeae

Anna Roditscheff, Konrad Egli, Andréj Vianin, Fabian Lörtscher, Jürgen Reidla, Faina Wehrli, Martin Risch, Lorenz Risch, Sven N Hobbie, Nadia Wohlwend, Thomas Bodmer

European Journal of Clinical Microbiology & Infectious Diseases · 2025

DOI: 10.1007/s10096-025-05053-4 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2025. Verfasst von Anna Roditscheff und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Dr. Risch, Liebefeld, Bern, Switzerland. anna.roditscheff@risch.ch. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Azithromycin, Ciprofloxacin, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Molecular methods to detect antimicrobial resistance in Neisseria gonorrhoeae (Ng) are increasingly needed worldwide to improve diagnostic tests and enable individualized patient treatments. The Allplex™ NG & DR Assay (NG & DR assay) was assessed for its ability to detect Ng and its antimicrobial resistance. The assay predicts ciprofloxacin resistance and susceptibility by targeting the molecular antimicrobial resistance (AMR) determinant gyrA S91F. The AMR determinants 23 S rRNA A2059G and C2611T were investigated to predict azithromycin wild-type and nonwild-type genotypes. METHODS: After antimicrobial susceptibility testing, 153 Ng isolates were evaluated with the NG & DR assay. Furthermore, 394 clinal specimens, including 76 with corresponding antimicrobial susceptibility results, were analyzed simultaneously by the NG & DR assay and the in-house SYBR-Green assay. RESULTS: The NG & DR assay predicted ciprofloxacin resistance and susceptibility with a sensitivity and specificity of 98.2% and 100.0%, respectively, and the results were consistent with those of the SYBR-Green assay for the detection of S91F. For the prediction of azithromycin nonwild-type and wild-type genotypes, the NG & DR assay demonstrated a sensitivity and specificity of 50.0% and 100.0%, respectively. CONCLUSION: The NG & DR assay demonstrated promising results for the molecular prediction of ciprofloxacin resistance and susceptibility, expanding the potential diagnostic tool kit for individualized patient treatment. Furthermore, it might serve as a surveillance tool for azithromycin nonwild-type strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neisseria gonorrhoeaeAzithromycinCiprofloxacinAnti-Bacterial AgentsDrug Resistance, BacterialMolecular Diagnostic TechniquesHumansMicrobial Sensitivity TestsGonorrheaRNA, Ribosomal, 23SSensitivity and SpecificityDNA GyraseGenotypeFemale

Stichwörter der Autor:innen

A2059GAllplex™ NG & DR assayAzithromycinC2611TCiprofloxacinGyrANeisseria gonorrhoeaeResistanceSeegene

Substanzen

AzithromycinCiprofloxacinAnti-Bacterial AgentsRNA, Ribosomal, 23SDNA Gyrase

Autor:innen und Institutionen

  • Laboratory Dr. Risch, Liebefeld, Bern, Switzerland. anna.roditscheff@risch.ch.
  • Faculty of Medical Science, Private University in the Principality of Liechtenstein (UFL), Triesen, Liechtenstein. anna.roditscheff@risch.ch.
  • Laboratory Dr. Risch, Liebefeld, Bern, Switzerland.
  • Laboratory Dr. Risch, Buchs, St. Gallen, Switzerland.
  • Faculty of Medical Science, Private University in the Principality of Liechtenstein (UFL), Triesen, Liechtenstein.
  • Institute of Medical Microbiology, University of Zurich, Zürich, Switzerland.

Zitieren

APA

Roditscheff, A., Egli, K., Vianin, A., Lörtscher, F., Reidla, J., Wehrli, F., Risch, M., Risch, L., Hobbie, S. N., Wohlwend, N., & Bodmer, T. (2025). Evaluation of the Allplex NG & DR assay for molecular prediction of ciprofloxacin and azithromycin resistance in Neisseria gonorrhoeae. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-025-05053-4

Vancouver

Roditscheff A, Egli K, Vianin A, Lörtscher F, Reidla J, Wehrli F, et al. Evaluation of the Allplex NG & DR assay for molecular prediction of ciprofloxacin and azithromycin resistance in Neisseria gonorrhoeae. European Journal of Clinical Microbiology & Infectious Diseases. 2025. doi:10.1007/s10096-025-05053-4

BibTeX
@article{Roditscheff2025,
  author = {Roditscheff, Anna and Egli, Konrad and Vianin, Andréj and Lörtscher, Fabian and Reidla, Jürgen and Wehrli, Faina and Risch, Martin and Risch, Lorenz and Hobbie, Sven N and Wohlwend, Nadia and Bodmer, Thomas},
  title = {Evaluation of the Allplex NG & DR assay for molecular prediction of ciprofloxacin and azithromycin resistance in Neisseria gonorrhoeae},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2025},
  doi = {10.1007/s10096-025-05053-4}
}
Kostenlos starten →